Active Funding Opportunity Announcements (FOAs) for All NICHD

NICHD issues and participates in various FOAs to support research activities and training.

Investigator-Initiated (Unsolicited) Projects

To submit unsolicited or investigator-initiated applications, use the appropriate NIH Parent Announcement.

Active FOAs for NICHD

Please note: The following FOAs are sorted by date, from most recent to oldest. Select a table heading to change how to sort and display the FOAs.

Announcement Number Submissions Date(s) Sort descending Expiration Date Activity Code(s) Title
PA-20-205 May 8, 2023 K23 Mentored Patient-Oriented Research Career Development Award (Parent K23 Independent Clinical Trial Not Allowed)
PAR-20-125 July 24, 2020; June 24, 2021

All applications are due by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on the listed date(s). Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
July 24, 2021 S06 Native American Research Centers for Health (NARCH) (S06 Clinical Trial Optional)
PAR-18-745 June 14, 2018, November 14, 2018, June 14, 2019, November 14, 2019, June 15, 2020 and November 13, 2020 by 5:00 PM local time of applicant organization. November 14, 2020 R21 Addressing the Challenges of the Opioid Epidemic in Minority Health and Health Disparities Research in the U.S. (R21 Clinical Trial Optional)
PAR-20-122 ?August 11, 2020, February 9, 2021, August 10, 2021, February 9, 2022 August 9, 2022, February 9, 2023 May 8, 2023 UG3/UH3 Blueprint Neurotherapeutics Network (BPN): Small Molecule Drug Discovery and Development of Disorders of the Nervous System (UG3/UH3 Clinical Trial Optional)
PA-18-590 A change of grantee organization request must be made before the anticipated start date at the new organization and preferably several months in advance. January 26, 2021 777 Change of Grantee Organization (Type 7 Parent Clinical Trial Optional)
PA-18-589 A successor-in-interest request must be made before the anticipated start date at the new organization and preferably several months in advance. January 26, 2021 666 Successor-in-Interest (Type 6 Parent Clinical Trial Optional)
PAR-18-951 April 15, 2019, April 15, 2020, April 15, 2021, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. April 16, 2021 U01 Opportunities for Collaborative Research at the NIH Clinical Center (U01 Clinical Trial Optional)
PAR-18-214 April 4, 2018; August 7, 2018; November 7, 2018; April 4, 2019; August 7, 2019; November 7, 2019; April 3, 2020 by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. August 8, 2020 R21 Translational Research in Pediatric and Obstetric Pharmacology and Therapeutics (R21 Clinical Trial Optional)
PAR-18-215 April 4, 2018; August 7, 2018; November 7, 2018; April 4, 2019; August 7, 2019; November 7, 2019; April 3, 2020, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. August 8, 2020 R01 Translational Research in Pediatric and Obstetric Pharmacology and Therapeutics (R01 Clinical Trial Optional)
PAR-20-111 August 11, 2020, February 9, 2021,August 10, 2021,February 9, 2022,August 9, 2022, February 9, 2023 by 5:00 PM local time of applicant organization. May 8, 2023 U44 Blueprint Neurotherapeutics Network (BPN): Small Molecule Drug Discovery and Development for Disorders of the Nervous System (U44 Clinical Trial Optional)
RFA-HD-21-009 August 14, 2020

All applications are due by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on the listed date(s). Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
August 15, 2020 P50 Intellectual and Developmental Disabilities Reserch Centers [IDDRC] FY 2021 (P50 Clinical Trial Optional)
PAR-19-283 August 20, 2019; August 20, 2020; August 20, 2021, by 5:00 PM local time of applicant organization. All types of AIDS and AIDS-related applications allowed for this funding opportunity announcement are due on these dates.

Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
August 21, 2021 D43 Fogarty HIV Research Training Program for Low-and Middle-Income Country Institutions (D43 Clinical Trial Optional)
PAR-20-243 August 20, 2020, December 2 , 2020, March 2, 2021 March 3, 2021 R01 Digital Healthcare Interventions to Address the Secondary Health Effects Related to Social, Behavioral, and Economic Impact of COVID-19 (R01 - Clinical Trial Optional)
PAR-18-854 August 23, 2018; September 13, 2018; October 10, 2018; November 13, 2018; December 11, 2018; January 10, 2019; February 11, 2019; March 11, 2019; April 11, 2019; May 10, 2019; June 10, 2019; July 11, 2019; August 9, 2019; September 12, 2019; October 11, 2019; November 13, 2019; December 10, 2019; January 10, 2020; February 10, 2020; March 10, 2020; April 7, 2020; May 11, 2020; June 10, 2020; July 10, 2020; August 11, 2020; September 10, 2020; October 14, 2020; November 10, 2020; December 11, 2020; January 11, 2021; February 10, 2021; March 10, 2021; April 9, 2021; May 10, 2021; June 11, 2021; July 9, 2021; August 10, 2021; September 10, 2021 by 5:00 PM local time of applicant organization. September 11, 2021 R01 Time-Sensitive Obesity Policy and Program Evaluation (R01 Clinical Trial Not Allowed)
PAR-20-237 August 28, 2020; December 1, 2020 December 2, 2020 R01 Community Interventions to Address the Consequences of the COVID-19 Pandemic among Health Disparity and Vulnerable Populations (R01- Clinical Trial Optional)
RFA-OD-20-013 August 7, 2020

No late applications will be accepted for this Funding Opportunity Announcement..
August 8, 2020 U24 Emergency Awards: RADx-UP Coordination and Data Collection Center (CDCC) (U24 Clinical Trial Optional)
RFA-HD-21-020 December 10, 2020, by 5:00 PM local time of applicant organization.
No late applications will be accepted for this Funding Opportunity Announcement
December 11, 2020 R43/R44 Non-invasive Diagnostics to Improve Gynecologic Health (R43/R44 Clinical Trial Optional)
PAR-18-950 December 11, 2018; December 11, 2019; December 11, 2020, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. December 12, 2020 X02 Pre-application: Opportunities for Collaborative Research at the NIH Clinical Center (X02 Clinical Trial Optional)
RFA-NS-19-011 December 13, 2018; April 15, 2019; December 13, 2019; April 15, 2020; December 15, 2020; April 15, 2021 , by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.

Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
April 16, 2021 F99/K00 NIH Blueprint Diversity Specialized Predoctoral to Postdoctoral Advancement in Neuroscience (D-SPAN) Award (F99/K00)
PAR-20-031 December 20, 2019; November 30, 2020; November 30, 2021 December 21, 2021 R01 Human-Animal Interaction (HAI) Research (R01 Clinical Trial Optional)
top of pageBACK TO TOP